Take-home-message

Artificial intelligence (AI) can be defined as the branch of computer science dealing with the simulation of intelligent human behavior in computers. It is done by creating algorithms that can solve problems and are programmed for all the specificities of the problem. Dermatology has taken the leading position for the implementation of AI in t...
Circulation: AHA Journals: Published July, 2023Hypertension management remains suboptimal globally, with treatment inertia being identified as one of the main barriers to achieving blood pressure (BP) control. Simpler approaches to achieve target BP levels are needed. TAKE-HOME MESSAGEThe QUARTET study examined the effectiveness of a quadrupl...
American Journal of Orthodontics and Dentofacial Orthopedics: Published: August 29, 2023TAKE-HOME MESSAGEThis study showed that, in patients with fixed orthodontic appliances, twice weekly use of 0.12% chlorhexidine (CHX) mouthwash reduced the plaque, gingival, and gingival bleeding indexes when evaluated at 15, 30, and 60 days of protocol imp...
Journal of Diabetes and its Complications: August 2023Nearly one out of three individuals will develop a psychiatric disorder during their life. Severe psychiatric disorders are associated with higher mortality rates, with 10–20 life-years lost compared to individuals without a severe psychiatric disorderSeveral psychiatric disorders are li...
JAMA Psychiatry: August, 2022The postpartum period is critical for mothers, children, and families, and approximately 10% to 15% of new mothers experience postpartum depression (PPD), one of the most common complications related to childbirth.PPD ranges from mild to severe episodes and includes similar symptoms as major depression outside...
Indian Journal of Pharmacology: Published: May, 2019Dermatophytic infections are the common fungal infections aggravated by hot and humid climate. Terbinafine and Itraconazole are commonly used oral antifungal agents for the same. However, resistance to these drugs is being seen increasingly when used in the conventional doses and duration. In...
Diabetes Care: May, 2023Type 2 diabetes is associated with increased risk of microvascular and macrovascular disease, with the risk of cardiovascular (CV) mortality more than double in people with type 2 diabetes compared with those without. In the last decade, large dedicated CV outcome trials in people with type 2 diabetes and at high risk or...
Seborrheic dermatitis (SD) is a chronic common inflammatory skin disease, affecting 1-3% of the adult population which is a common chronic erythematous scaly eruption usually seen in areas rich in sebaceous glands, the scalp, face, chest, back, and flexural areas.Malassezia yeasts have been implicated in the pathogenesis of this disease. Antif...
JAMA Dermatology: Published November, 2022Despite the widespread use of nutritional supplements and dietary interventions for treating hair loss, the safety and effectiveness of available products remain unclear.The aim of the study is to evaluate and compile the findings of all dietary and nutritional interventions for treatment of hair loss a...
The British Journal of DermatologyDermatophytic infections have undergone unprecedented changes in India in the recent past. Oral antifungal drugs are considered to have a high cure rate in tinea corporis, tinea cruris and tinea faciei.Clinical trials to find out the effectiveness of the four main oral antifungal drugs are lacking.Authors teste...
Superficial fungal infections are primarily caused by dermatophytes, Candida spp, and Malassezia species affects 20%–25% of the world’s population.The lesion of dermatophytosis is present with an annular or ring-shaped red scaly plaque with central clearing, often associated with severe pruritus.Systemic or topical antifungal drugs are used as...
JAMA Internal Medicine: Published on May, 2023Diabetic kidney disease is the leading cause of chronic kidney disease and end-stage kidney failure in the vast majority of the world. TAKE-HOME MESSAGEThis randomized clinical trial evaluated the use of glucose-lowering medications on kidney outcomes. A total of 5047 patients with type 2 diabet...